Acne
Acne, or acne vulgaris, is a chronic inflammatory skin condition characterized by comedones (blackheads and whiteheads), pimples, and oily skin caused by clogged hair follicles from excess sebum and dead skin cells. It primarily affects areas with many oil glands, such as the face, chest, and back, and can lead to scarring, anxiety, reduced self-esteem, and, in severe cases, depression.
Health Outcomes
- Absence of Adverse Physiological Effects
- Absence of Antibiotic Resistance
- Absence of Deep Epithelial Disruption
- Absence of Pathological Inflammation
- Absence of Serious Adverse Events
- Absence of Serious Side Effects
- Absence of Serious Symptoms such as Septic Shock
- Absence of Severe Adverse Reactions
- Absence of Treatment-Related Side Effects
- Altered Hydrophobicity
- Antibacterial Activity Against Bacillus subtilis
- Asymptomatic or Mild Symptoms
- Cosmetic Material Identification
- Enhanced Antibacterial Effect
- Enhanced Antimicrobial Peptide Levels
- Enhanced Antimicrobial Peptide Production
- Enhanced Epithelial Cell Migration
- Enhanced Host Defense Peptides Activation
- Enhanced Host-Microbe Balance
- Enhanced Phagocytic Function
- Enhanced Phototherapy Outcome
- Enhanced Safety in Topical Application
- Enhanced Skin Gloss
- Enhanced β-Defensin 3 Activity
- Few Adverse Effects
- Good Tolerability
- High Treatment Acceptability
- Improved Antibacterial Activity
- Improved Antibacterial Activity in Skin Mucus
- Improved Consumer Acceptability
- Improved Consumer Acceptance
- Improved Dermatology Life Quality Index
- Improved Ease of Use
- Improved Health Outcome Relative to Zinc Bacitracin
- Improved Keratinocyte Differentiation
- Improved Lesion Regression
- Improved Microbial Structures
- Improved Phagocytic Activity
- Improved Phagocytic Activity of Macrophages
- Improved Quorum Sensing Signaling
- Improved Skin Cell Proliferation
- Improved Skin Condition
- Improved Skin Condition Score
- Improved Skin Disease Severity
- Improved Skin Health
- Improved Skin Recovery
- Improved Skin Responses
- Improved Skin Satisfaction
- Improved Skin Symptoms
- Increased Aerobic Microorganism Count Over 15 Days
- Increased Collagen Synthesis
- Increased Epithelial Proliferation
- Increased Expression of Antimicrobial Peptide Genes
- Increased Expressions of β-Defensins
- Increased Free Testosterone Level
- Increased Host Defense Peptide Levels
- Increased LL-37 Levels
- Increased Neutrophil Activity
- Increased Propionibacterium Acnes Levels
- Increased Skin Sebum Production
- Increased Surface Activity
- Increased Survival in Acidic Environment
- Increased Tetracycline Resistance
- Increased Total Anaerobic Gram-Positive Bacteria Counts
- Inhibited Adhesion of Staphylococcus Aureus
- No Adverse Effect on Food Intake or Body Measurements
- No Adverse Effects
- No Adverse Effects on Body Weight or Food Intake
- No Adverse Effects on Food Intake
- No Adverse Health Effects
- No Adverse Side Effects
- No Change in Anthropometric Parameters
- No Change in Antibiotic Usage
- No Change in Body Composition
- No Change in Complete Symptom Cessation
- No Change in Cytokine Levels
- No Change in Growth Metrics
- No Change in Immune Parameters
- No Change in Immune System Response
- No Change in Inflammatory or Anti-inflammatory Cytokine Levels
- No Change in Proinflammatory Cytokine Secretion
- No Change in Sleep Quality
- No Effect on Growth Parameters
- No Effect on Immune Response to Influenza Vaccination
- No Effect on Staphylococcus aureus
- No Histological Dysfunction
- No Impact on Fatigue
- No Increase in Adverse Effects
- No Influence on Oropharyngeal Microbiota
- No Long-Term Impact on Gut Microbiota
- No Mortality or Toxicity
- No Negative Impact on Hematological Parameters
- No Reported Adverse Effects
- No Serious Adverse Effects
- No Significant Adverse Events
- No Significant Adverse Events or Changes in Clinical Parameters
- No Significant Change in Blood Indices
- No Significant Change in GPT, GOT, Glucose Levels
- No Significant Change in Health Variables
- No Significant Change in Inflammatory Responses
- No Significant Changes in Blood Parameters
- No Significant Effect on Anxiety Levels
- No Significant Effect on Diarrhea
- No Significant Effect on Glucose Metabolism
- No Significant Effect on Gross Pathology
- No Significant Effect on Negative Mood States
- No Significant Impact on Bacterial Community Composition or Diversity
- No Significant Increase in Adverse Effects
- No Significant Safety Parameter Changes
- No Significant Weight Change
- Nonpathogenic Condition
- Nonpathogenic for Mice
- Occurrence of Mild Adverse Events
- Potential Skin Effect
- Potentially Effective Antibacterial Proteins
- Recovered Without Further Complications
- Reduced Acne Erythema
- Reduced Acne Lesions
- Reduced Acne Severity
- Reduced Adhesion of Streptococcus pyogenes to Human Cells
- Reduced Apoptotic Shedding of Epithelial Cells
- Reduced Clinical Disease Signs
- Reduced Colony Colonization by Pathogenic Organisms
- Reduced Erythema Intensity
- Reduced Facial Skin Pores
- Reduced Growth of Harmful Bacteria
- Reduced Inflammatory Infiltrate
- Reduced Investigator Global Assessment
- Reduced Lesion Size
- Reduced Localized Infection
- Reduced Methanobrevibacter Levels
- Reduced Microbial Growth
- Reduced Pathogen Adherence
- Reduced Pathogenic Bacterial Activity
- Reduced Pathological Symptoms
- Reduced S. aureus Adhesion
- Reduced S. aureus Cell Count In Vivo
- Reduced Sebum Triglycerides
- Reduced Skin Inflammation
- Reduced Skin Redness
- Reduced Staphylococcal Counts
- Reduced Staphylococcus Aureus Virulence
- Reduced Staphylococcus aureus Colonization
- Reduced Staphylococcus aureus Growth
- Reduced Treatment Duration
- Resolved Lesion
- Restored Microbial Balance
- Stabilized Skin Microbiome
- Unchanged Inflammatory Response
- Unchanged Microbiome Alpha-Diversity
- Unchanged Risk of Sepsis
- Well Tolerated Treatment